Phase 3 Idiopathic Short Stature Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Turner SyndromeIdiopathic Short StatureShort Stature Homeobox Gene Mutation+1 more
Ascendis Pharma A/S186 enrolled11 locationsNCT07221851
Recruiting
Phase 3
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
Idiopathic Short Stature
Xiamen Amoytop Biotech Co., Ltd.300 enrolled38 locationsNCT06927310